Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention

JAMA

Volumn 287, Issue 2, 2002, Pages 210-215

  Mehilli, Julinda ^a   Kastrati, Adnan ^a   Dirschinger, Josef ^a   Pache, Jürgen ^a   Seyfarth, Melchior ^b   Blasini, Rudolf ^a   Hall, Donald ^a   Neumann, Franz Josef ^b   Schömig, Albert ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; NITRATE; SIMVASTATIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SMOKING; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0037045440     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.2.210     Document Type: Article

References (40)

1. Sex differences in mortality after myocardial infarction: Is there evidence for an increased risk for women?
2. Myocardial infarction in women: A critical appraisal of gender differences in outcomes
3. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke
4. Thrombolytic therapy for women with myocardial infarction: Is there a gender gap?
5. Comparison of clinical outcomes for women and men after acute myocardial infarction
6. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy
7. A comparison of the early outcome of acute myocardial infarction in women and men
8. Sex, clinical presentation, and outcome in patients with acute coronary syndromes
9. Acute myocardial infarction in women: Contribution of treatment variables to adverse outcome
10. Differences between women and men in survival after myocardial infarction: Biology or methodology?
11. In-hospital and 1-year mortality in 1524 women after myocardial infarction: Comparison with 4315 men
12. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: Is there evidence for a gender bias?
13. Sex differences in the management and long-term outcome of acute myocardial infarction: A statewide study: Myocardial Infarction Data Acquisition System
14. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991: Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women
15. Sex differences in mortality after myocardial infarction: Evidence for a sexage interaction
16. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2
17. Sex-based differences in early mortality after myocardial infarction
18. Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study
19. Sex differences in 2-year mortality after hospital discharge for myocardial infarction
20. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
21. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction
22. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
23. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction
24. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
25. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3
26. Gender-related differences in reperfusion treatment allocation and outcome for acute myocardial infarction
27. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction
28. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction
29. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting
30. Sex-related differences in patients undergoing direct angioplasty for acute myocardial infarction
31. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction
32. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-Year results from 37 WHO MONICA project populations: Monitoring trends and determinants in cardiovascular disease
33. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
34. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction
35. Optimizing percutaneous coronary revascularization in diabetic women: Analysis from the EPISTENT trial
36. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1
37. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
38. Early statin treatment following acute myocardial infarction and 1-year survival